HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Poly[N-(2-hydroxypropyl)methacrylamide] conjugates of bovine pancreatic ribonuclease (RNase A) inhibit growth of human melanoma in nude mice.

Abstract
Recently hydrophilic poly[N-(2-hydroxypropyl)methacrylamide] (PHPMA) was used for BS-RNase modification to prevent its degradation in bloodstream or fast elimination. Polymer-conjugated BS-RNase preparations proved to be cytotoxic after intravenous or intraperitoneal application, whereas native BS-RNase was ineffective. Here RNase A unimer was conjugated with two HPMA polymers (classic and star) and their antitumor effects both in vitro and in vivo were compared with those of BS-RNase polymers. Surprisingly, the antitumor effect of RNase A conjugates was also pronounced. The RNase A conjugates (classic and star) injected intravenously to mice bearing melanoma tumor caused a significant reduction in tumor volume following ten doses of 5 and 1 mg/kg, respectively. Despite the antitumor activity observed in vivo, the in vitro tested cytotoxic activity of RNase A did not differ from that caused by native RNase A while native BS-RNase (50 microg/ml) totally inhibited DNA synthesis in treated cells. The experiments with 125I-labeled preparations demonstrated concentration-dependent internalization of native BS-RNase by tumor cells within an hour, whereas the polymer conjugate (S-BS) was not internalized. On the contrary, the in vivo experiments showed that whereas 40% of S-BS conjugate persisted in bloodstream for 24h after administration, 98% of the native BS-RNase was already eliminated. Improved antitumor activities of PHPMA-modified RNases in vivo might be ascribed to their prolonged retention in bloodstream, better proteolytic stability and resistance to the action of the ribonuclease inhibitor.
AuthorsJ Soucek, P Poucková, J Strohalm, D Plocová, D Hlousková, M Zadinová, K Ulbrich
JournalJournal of drug targeting (J Drug Target) Vol. 10 Issue 3 Pg. 175-83 (May 2002) ISSN: 1061-186X [Print] England
PMID12075818 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Drug Carriers
  • Iodine Radioisotopes
  • Polymethacrylic Acids
  • Duxon
  • Endoribonucleases
  • ribonuclease SPL
  • Ribonuclease, Pancreatic
Topics
  • Animals
  • Antineoplastic Agents (administration & dosage, chemistry, therapeutic use)
  • Binding Sites (physiology)
  • Cattle
  • Dose-Response Relationship, Drug
  • Drug Administration Routes
  • Drug Carriers
  • Endoribonucleases (administration & dosage, chemistry, therapeutic use)
  • Female
  • Humans
  • Injections, Intraperitoneal
  • Injections, Intravenous
  • Iodine Radioisotopes
  • Lymphocytes (metabolism)
  • Melanoma, Experimental (drug therapy, pathology)
  • Mice
  • Mice, Nude
  • Molecular Structure
  • Polymethacrylic Acids (administration & dosage, chemistry)
  • Protein Conformation
  • Ribonuclease, Pancreatic (administration & dosage, chemistry, therapeutic use)
  • Tumor Cells, Cultured (metabolism)
  • Xenograft Model Antitumor Assays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: